In December 2015, Shkreli was arrested by the FBI after being indicted on federal charges of securities fraud. He subsequently as CEO of Turing Pharmaceuticals and was replaced by the company's board chairman, Ron Tilles. Shkreli was convicted of two counts of securities fraud and one count of conspiring to commit securities fraud in August 2017.